LAILA ADAMS: Open Payments
NPI 1932672151 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 55 payments from 13 companies in 2025. Trend: 2023 $320 · 2024 $538 · 2025 $1,067
Food & beverage: $897Education: $171
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $537 |
| Janssen Biotech, Inc. | 3 | $125 |
| Regeneron Healthcare Solutions, Inc. | 2 | $101 |
| UCB, Inc. | 3 | $80 |
| Organon LLC | 5 | $56 |
| Almirall LLC | 1 | $33 |
| Lilly USA, LLC | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $19 |
Products named: SKYRIZI, RINVOQ, TREMFYA, DUPIXENT, Bimzelx, Klisyri, TALTZ, Sotyktu.
Industry payments across PA — which companies pay providers there.
